TNXP Latest Press Releases

-- January 30, 2026 --

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit Globe Newswire 7:00 AM

-- January 6, 2026 --

Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026 Globe Newswire 7:00 AM

-- December 29, 2025 --

Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering Globe Newswire 7:57 AM

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800) Globe Newswire 7:45 AM

-- December 16, 2025 --

Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University Globe Newswire 7:00 AM

-- December 9, 2025 --

Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel Globe Newswire 7:00 AM

-- December 4, 2025 --

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations Globe Newswire 8:30 AM

-- November 24, 2025 --

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder Globe Newswire 7:00 AM

-- November 17, 2025 --

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment Globe Newswire 7:00 AM

-- November 10, 2025 --

Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights Globe Newswire 4:15 PM

-- November 6, 2025 --

Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference Globe Newswire 7:00 AM

-- November 4, 2025 --

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection Globe Newswire 7:00 AM

-- October 30, 2025 --

Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP) AB Digital Inc 2:49 PM

-- October 28, 2025 --

Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025 Globe Newswire 7:00 AM

-- October 27, 2025 --

Tonix Pharmaceuticals Presented Data on Tonmya (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence Globe Newswire 7:00 AM

-- October 22, 2025 --

Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix's Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital Globe Newswire 7:00 AM

-- October 21, 2025 --

Tonix Pharmaceuticals to Present Poster on Tonmya at the 2025 American College of Rheumatology (ACR) Convergence Globe Newswire 7:00 AM

-- October 17, 2025 --

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress-Europe 2025 Globe Newswire 7:00 AM

-- October 14, 2025 --

Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation Globe Newswire 7:00 AM

-- October 9, 2025 --

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025 Globe Newswire 7:00 AM

-- September 30, 2025 --

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access Globe Newswire 8:30 AM

-- September 29, 2025 --

Tonix Pharmaceuticals Plans to Initiate Prader-Willi Syndrome Phase 2 Trial of TNX-2900 (Intranasal Potentiated Oxytocin) in 2026 Globe Newswire 7:00 AM

-- September 18, 2025 --

Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder Globe Newswire 8:00 AM

-- September 17, 2025 --

Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800) Globe Newswire 7:00 AM

-- September 8, 2025 --

Tonix Pharmaceuticals Presents Clinical Data on Tonmya for the Treatment of Fibromyalgia at PAINWEEK 2025 Globe Newswire 7:00 AM